Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
J Clin Oncol
; 41(36): 5550-5560, 2023 Dec 20.
Article
em En
| MEDLINE
| ID: mdl-37801674
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Imunoconjugados
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article